Celia Chen

Celia (Wenjun) Chen is a skilled Research Technician with extensive experience in cancer research and clinical studies. Currently, Celia holds positions at Ranomics and The Structural Genomics Consortium, contributing to projects focused on the role of PRMT5 in glioblastoma and breast cancer, as well as conducting drug screenings for potential cancer therapies. Previously, Celia worked as a Clinical Research Assistant at the Centre for Addiction and Mental Health, investigating gemfibrozil for smoking cessation in a clinical trial. Celia's background also includes customer service experience at the Industrial and Commercial Bank of China and research roles at the University of Toronto, where studies focused on inflammation in bipolar disorder and DNA repair mechanisms. Celia earned a Master of Science in Applied Clinical Pharmacology and a Bachelor of Science in Pharmacology and Toxicology from the University of Toronto.